{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:56:41Z","timestamp":1792155401340,"version":"4.4.0"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020721","name":"University of Lagos","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031746","name":"Science for Africa Foundation","doi-asserted-by":"publisher","award":["GCA-R13-01"],"award-info":[{"award-number":["GCA-R13-01"]}],"id":[{"id":"10.13039\/100031746","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ejpb.2025.114831","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T22:56:49Z","timestamp":1754434609000},"page":"114831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Advancements in drug delivery systems for women\u2019s reproductive health: Vaginal microbiome as a target for innovative drug delivery systems"],"prefix":"10.1016","volume":"215","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5419-8281","authenticated-orcid":false,"given":"Peace-OfonAbasi O.","family":"Bassey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret O.","family":"Ilomuanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bukola A.","family":"Oseni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Ogundemuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karamot O.","family":"Oyediran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evans N.","family":"Ekeji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Abia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2025.114831_b0005","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1053\/j.ajkd.2019.04.017","article-title":"Women\u2019s Reproductive Health for the Nephrologist","volume":"74","author":"Burgner","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ejpb.2025.114831_b0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12978-020-0899-y","article-title":"Emerging infectious diseases and outbreaks: implications for women\u2019s reproductive health and rights in resource-poor settings","volume":"17","author":"Chattu","year":"2020","journal-title":"Reprod. Health"},{"key":"10.1016\/j.ejpb.2025.114831_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/frph.2022.963752","article-title":"The female reproductive tract microbiotas, inflammation, and gynecological conditions","author":"Gholiof","year":"2022","journal-title":"Frontiers in Reproductive Health 4"},{"key":"10.1016\/j.ejpb.2025.114831_b0020","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.3390\/ijms24065682","article-title":"Endocrine Disruptor Compounds in Environment: Focus on Women\u2019s Reproductive Health and Endometriosis","volume":"24","author":"Interdonato","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2025.114831_b0025","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.3390\/molecules26195905","article-title":"Controlled Drug delivery Systems: Current Status and Future Directions","volume":"26","author":"Adepu","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2025.114831_b0030","doi-asserted-by":"crossref","unstructured":"K.K. Jain, An Overview of Drug Delivery Systems, in: 2020: pp. 1\u201354. Doi: 10.1007\/978-1-4939-9798-5_1.","DOI":"10.1007\/978-1-4939-9798-5_1"},{"key":"10.1016\/j.ejpb.2025.114831_b0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-019-0068-3","article-title":"Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles","volume":"4","author":"Singh","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ejpb.2025.114831_b0040","doi-asserted-by":"crossref","unstructured":"C. Chopra, I. Bhushan, M. Mehta, T. Koushal, A. Gupta, S. Sharma, M. Kumar, S. Al Khodor, S. Sharma, Vaginal Microbiome: Considerations For Reproductive Health, Future Microbiol 17 (2022) 1501\u20131513. Doi: 10.2217\/fmb-2022-0112.","DOI":"10.2217\/fmb-2022-0112"},{"key":"10.1016\/j.ejpb.2025.114831_b0045","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/jobm.202100421","article-title":"Insights into the role of vaginal microbiome in women\u2019s health","volume":"61","author":"Deka","year":"2021","journal-title":"J. Basic Microbiol."},{"key":"10.1016\/j.ejpb.2025.114831_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103696","article-title":"Crosstalk between Vaginal Microbiome and Female Health: a review","volume":"136","author":"Gupta","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ejpb.2025.114831_b0055","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1515\/jpm-2020-0367","article-title":"Implications of the vaginal microbiome and potential restorative strategies on maternal health: a narrative review","volume":"49","author":"Moumne","year":"2021","journal-title":"J. Perinat. Med."},{"key":"10.1016\/j.ejpb.2025.114831_b0060","article-title":"The correlation between vaginal microecological dysbiosis-related diseases and preterm birth: a review","volume":"8","author":"Gao","year":"2021","journal-title":"Med. Microecol."},{"key":"10.1016\/j.ejpb.2025.114831_b0065","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1007\/s00203-021-02414-3","article-title":"Vaginal microbiome: normalcy vs dysbiosis","volume":"203","author":"Saraf","year":"2021","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.ejpb.2025.114831_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2024.101304","article-title":"Insights into Women\u2019s health: Exploring the vaginal microbiome, quorum sensing dynamics, and therapeutic potential of quorum sensing quenchers","volume":"100","author":"N\u00fa\u00f1o","year":"2024","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.ejpb.2025.114831_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11050217","article-title":"Modifications in vaginal microbiota and their influence on drug release: challenges and opportunities","volume":"11","author":"Leyva-G\u00f3mez","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114831_b0080","unstructured":"D. DI Ricerca In Scienze Biotecnologiche E Farmaceutiche, C. Profssa Maria Laura Bolognesi Profssa Barbara Luppi, Presentata da: Dott.ssa Barbara Giordani Coordinatore Dottorato Supervisore, n.d."},{"key":"10.1016\/j.ejpb.2025.114831_b0085","first-page":"1","article-title":"Promising drug delivery approaches to treat microbial infections in the vagina: a recent update","volume":"23","author":"Pandey","year":"2021","journal-title":"Polymers (basel)"},{"key":"10.1016\/j.ejpb.2025.114831_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/gels4020047","article-title":"Application of polysaccharide-based hydrogels as probiotic delivery systems","volume":"4","author":"Kwiecie\u0144","year":"2018","journal-title":"Gels"},{"key":"10.1016\/j.ejpb.2025.114831_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.00467","article-title":"Determinants of Vaginal Microbiota Composition","volume":"10","author":"Moosa","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejpb.2025.114831_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/prp2.787","article-title":"Probiotic lactobacilli in formulas and hygiene products for the health of the urogenital tract","volume":"9","author":"Nader-Mac\u00edas","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.ejpb.2025.114831_b0105","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12934-020-01464-4","article-title":"Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health","volume":"19","author":"Chee","year":"2020","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.ejpb.2025.114831_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054379","article-title":"Characterization of the Vaginal Micro- and Mycobiome in Asymptomatic Reproductive-Age Estonian Women","volume":"8","author":"Drell","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2025.114831_b0115","first-page":"2337","article-title":"Formulation and Optimization of Metronidazole and Lactobacillus spp","volume":"14","author":"Ilomuanya","year":"2022","journal-title":"Layered Suppositories via a Three-Variable, Five-Level Central Composite Design for the Management of Bacterial Vaginosis, Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114831_b0120","doi-asserted-by":"crossref","unstructured":"M.O. Ilomuanya, P.O. Bassey, D.A. Ogundemuren, U.N. Ubani-ukoma, A. Tsamis, Y. Fan, K. Michalakis, P. Angsantikul, A. Usman, A.N. Amenaghawon, Development of Mucoadhesive Electrospun Scaffolds for Intravaginal Delivery of Lactobacilli spp ., a Tenside , and Metronidazole for the Management of Bacterial Vaginosis, (2023).","DOI":"10.3390\/pharmaceutics15041263"},{"key":"10.1016\/j.ejpb.2025.114831_b0125","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejogrb.2019.12.035","article-title":"Bacterial vaginosis\u2014A brief synopsis of the literature","volume":"245","author":"Coudray","year":"2020","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"key":"10.1016\/j.ejpb.2025.114831_b0130","first-page":"1","article-title":"The Female Vaginal Microbiome in Health and Bacterial Vaginosis","volume":"11","author":"Chen","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejpb.2025.114831_b0135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s40168-022-01400-1","article-title":"Vaginal microbiome-host interactions modeled in a human vagina-on-a-chip","volume":"10","author":"Mahajan","year":"2022","journal-title":"Microbiome"},{"key":"10.1016\/j.ejpb.2025.114831_b0140","doi-asserted-by":"crossref","unstructured":"O. Adeyemi, M. Toure, N. Covic, M. van den Bold, N. Nisbett, D. Headey, Understanding drivers of stunting reduction in Nigeria from 2003 to 2018: a regression analysis, Food Secur 14 (2022) 995\u20131011. Doi: 10.1007\/s12571-022-01279-8.","DOI":"10.1007\/s12571-022-01279-8"},{"key":"10.1016\/j.ejpb.2025.114831_b0145","unstructured":"A.D. Parker, A Comparison of Metagenomic Sequencing Using Targeted 16S and Whole Genome Shotgun NGS on Microbial DNA Samples, (2021)."},{"key":"10.1016\/j.ejpb.2025.114831_b0150","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154944","article-title":"Next-generation sequencing: insights to advance clinical investigations of the microbiome","volume":"132","author":"Wensel","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejpb.2025.114831_b0155","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41586-019-1238-8","article-title":"The Integrative Human Microbiome Project","volume":"569","author":"Proctor","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2025.114831_b0160","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbx051","article-title":"Bioinformatics tools for quantitative and functional metagenome and metatranscriptome data analysis in microbes","author":"Niu","year":"2017","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.ejpb.2025.114831_b0165","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.tim.2019.07.006","article-title":"Host\u2013Pathogen Interactions during Female Genital Tract Infections","volume":"27","author":"Pekmezovic","year":"2019","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ejpb.2025.114831_b0170","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/humrep\/deac094","article-title":"The healthy female microbiome across body sites: effect of hormonal contraceptives and the menstrual cycle","volume":"37","author":"Krog","year":"2022","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ejpb.2025.114831_b0175","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1007\/s43032-020-00438-6","article-title":"Changes in the Vaginal Microbiome during the Pregnancy to Postpartum transition","volume":"28","author":"Nunn","year":"2021","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.ejpb.2025.114831_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2021.151654","article-title":"Air pollution and endocrine disruptors induce human microbiome imbalances: a systematic review of recent evidence and possible biological mechanisms","volume":"816","author":"Mousavi","year":"2022","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.ejpb.2025.114831_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2015.00081","article-title":"Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health","volume":"6","author":"Petrova","year":"2015","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejpb.2025.114831_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036466","article-title":"A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy","volume":"7","author":"Aagaard","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2025.114831_b0195","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.2147\/IJN.S337427","article-title":"Advancements in the pharmaceutical applications of probiotics: Dosage forms and formulation technology","volume":"16","author":"Baral","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejpb.2025.114831_b0200","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jconrel.2024.08.037","article-title":"Design of probiotic delivery systems and their therapeutic effects on targeted tissues","volume":"375","author":"Xu","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114831_b0205","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/1471-0528.15910","article-title":"The need for better evidence to support probiotics for vaginitis","volume":"127","author":"Hillier","year":"2020","journal-title":"BJOG"},{"key":"10.1016\/j.ejpb.2025.114831_b0210","doi-asserted-by":"crossref","DOI":"10.3390\/gels9030244","article-title":"Preclinical potential of Probiotic-Loaded Novel Gelatin\u2013Oil Vaginal Suppositories: Efficacy, Stability, and Safety Studies","volume":"9","author":"Bassi","year":"2023","journal-title":"Gels"},{"key":"10.1016\/j.ejpb.2025.114831_b0215","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2017.12.004","article-title":"Polymeric gels for intravaginal drug delivery","volume":"270","author":"Cook","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114831_b0220","doi-asserted-by":"crossref","unstructured":"J. das Neves, F. Notario-P\u00e9rez, B. Sarmento, Women-specific routes of administration for drugs: A critical overview, Adv Drug Deliv Rev 176 (2021) 113865. Doi: 10.1016\/j.addr.2021.113865.","DOI":"10.1016\/j.addr.2021.113865"},{"key":"10.1016\/j.ejpb.2025.114831_b0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.addr.2015.06.008","article-title":"New strategies for local treatment of vaginal infections","volume":"92","author":"Palmeira-de-Oliveira","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2025.114831_b0230","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/gels8020099","article-title":"Application of Sol\u2013Gels for Treatment of Gynaecological Conditions\u2014Physiological Perspectives and Emerging Concepts in Intravaginal Drug delivery","volume":"8","author":"Thapa","year":"2022","journal-title":"Gels"},{"key":"10.1016\/j.ejpb.2025.114831_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113950","article-title":"Targeted drug delivery for maternal and perinatal health: challenges and opportunities","volume":"177","author":"Sharma","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2025.114831_b0240","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.618411","article-title":"Advances in Oral Drug delivery","volume":"12","author":"Alqahtani","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114831_b0245","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.mpaic.2022.12.023","article-title":"Factors affecting drug absorption and distribution","volume":"24","author":"Bertram-Ralph","year":"2023","journal-title":"Anaesthesia & Intensive Care Medicine"},{"key":"10.1016\/j.ejpb.2025.114831_b0250","doi-asserted-by":"crossref","unstructured":"M. Zhao, Y. Wang, M. Chen, B. Wu, Introduction to Pharmacokinetics, in: Circadian Pharmacokinetics, Springer Singapore, Singapore, 2020: pp. 23\u201340. Doi: 10.1007\/978-981-15-8807-5_2.","DOI":"10.1007\/978-981-15-8807-5_2"},{"key":"10.1016\/j.ejpb.2025.114831_b0255","doi-asserted-by":"crossref","unstructured":"Y. Rojanasakul, C.J. Malanga, Parenteral Routes of Delivery, in: Theory and Practice of Contemporary Pharmaceutics, CRC Press, 2021: pp. 387\u2013419. Doi: 10.1201\/9780203644478-16.","DOI":"10.1201\/9780203644478-16"},{"key":"10.1016\/j.ejpb.2025.114831_b0260","unstructured":"R. Mazraani, Pelvic inflammatory disease in women; improving diagnosis and better understanding the disease process, (2021). https:\/\/opus.lib.uts.edu.au\/handle\/10453\/148950."},{"key":"10.1016\/j.ejpb.2025.114831_b0265","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.addr.2021.04.009","article-title":"Vaginal drug delivery approaches for localized management of cervical cancer","volume":"174","author":"Wang","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2025.114831_b0270","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ijpharm.2018.09.003","article-title":"Vaginal Bifidobacterium breve for preventing urogenital infections: Development of delayed release mucoadhesive oral tablets","volume":"550","author":"Giordani","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114831_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105606","article-title":"Vaginosis: advances in new therapeutic development and microbiome restoration","volume":"168","author":"Mohankumar","year":"2022","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ejpb.2025.114831_b0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nano11020311","article-title":"Recent advances in nanosystems and strategies for vaginal delivery of antimicrobials","volume":"11","author":"Chindamo","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ejpb.2025.114831_b0285","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s44222-023-00040-w","article-title":"Delivery technologies for women\u2019s health applications","volume":"1","author":"Swingle","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.ejpb.2025.114831_b0290","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3390\/ijms19061549","article-title":"Approaches in Polymeric Nanoparticles for Vaginal Drug delivery: a Review of the State of the Art","volume":"19","author":"Leyva-G\u00f3mez","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2025.114831_b0295","doi-asserted-by":"crossref","unstructured":"J.K. Patra, G. Das, L.F. Fraceto, E.V.R. Campos, M. del P. Rodriguez-Torres, L.S. Acosta-Torres, L.A. Diaz-Torres, R. Grillo, M.K. Swamy, S. Sharma, S. Habtemariam, H.-S. Shin, Nano based drug delivery systems: recent developments and future prospects, J Nanobiotechnology 16 (2018) 71. Doi: 10.1186\/s12951-018-0392-8.","DOI":"10.1186\/s12951-018-0392-8"},{"key":"10.1016\/j.ejpb.2025.114831_b0300","doi-asserted-by":"crossref","unstructured":"R.N. Wadetwar, P.S. Kanojiya, Vaginal Nano\u2010Based Drug Delivery System, in: Nanopharmaceutical Advanced Delivery Systems, Wiley, 2021: pp. 357\u2013377. Doi: 10.1002\/9781119711698.ch16.","DOI":"10.1002\/9781119711698.ch16"},{"key":"10.1016\/j.ejpb.2025.114831_b0305","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1080\/14656566.2018.1519549","article-title":"Advances in contraceptive vaginal rings: what does the future hold?","volume":"19","author":"Monteiro","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ejpb.2025.114831_b0310","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jconrel.2020.12.044","article-title":"Advances in controlled release hormonal technologies for contraception: a review of existing devices, underlying mechanisms, and future directions","volume":"330","author":"Sivasankaran","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114831_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119659","article-title":"Bacterial vaginosis: Standard treatments and alternative strategies","volume":"587","author":"Tom\u00e1s","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114831_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119733","article-title":"Characterization and in vitro evaluation of a vaginal gel containing Lactobacillus crispatus for the prevention of gonorrhea","author":"N\u2019Guessan Gnaman","year":"2020","journal-title":"Int J Pharm 588"},{"key":"10.1016\/j.ejpb.2025.114831_b0325","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.3390\/pathogens10121576","article-title":"Antimicrobial activity of a Vaginal Gel Formulation: Considerations Related to Vaginal Infection and Dysbiosis","volume":"10","author":"De Seta","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.ejpb.2025.114831_b0330","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10856-020-6359-y","article-title":"Long lasting mucoadhesive membrane based on alginate and chitosan for intravaginal drug delivery","volume":"31","author":"Tentor","year":"2020","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.ejpb.2025.114831_b0335","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijbiomac.2019.02.092","article-title":"S-protected gellan gum: Decisive approach towards mucoadhesive antimicrobial vaginal films","volume":"130","author":"Jalil","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2025.114831_b0340","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2018.12.011","article-title":"Chitosan-hydroxypropyl methylcellulose tioconazole films: a promising alternative dosage form for the treatment of vaginal candidiasis","volume":"556","author":"Calvo","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114831_b0345","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/2230-973X.176487","article-title":"Formulation, development and characterization of mucoadhesive film for treatment of vaginal candidiasis","volume":"6","author":"Mishra","year":"2016","journal-title":"Int J Pharm Investig"},{"key":"10.1016\/j.ejpb.2025.114831_b0350","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/polym13010026","article-title":"Win Yi, Promising Drug delivery Approaches to Treat Microbial Infections in the Vagina: a recent Update","volume":"13","author":"Pandey","year":"2020","journal-title":"Polymers (basel)"},{"key":"10.1016\/j.ejpb.2025.114831_b0355","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.3390\/ma13071709","article-title":"Chitosan\/Poly(2-ethyl-2-oxazoline) Films with Ciprofloxacin for Application in Vaginal Drug delivery","volume":"13","author":"Abilova","year":"2020","journal-title":"Materials"},{"key":"10.1016\/j.ejpb.2025.114831_b0360","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.3390\/ijms20153686","article-title":"Design and Characterization of Chitosan Nanoformulations for the delivery of Antifungal Agents","volume":"20","author":"Calvo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2025.114831_b0365","series-title":"Department of Dermatology , University of California , San Diego , La Jolla , California Division of Allergy and Immunology , Department of Pediatrics , National Jewish","first-page":"1","author":"Gonzalez","year":"2021"},{"key":"10.1016\/j.ejpb.2025.114831_b0370","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/jsm.12125","article-title":"Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial","volume":"10","author":"Chen","year":"2013","journal-title":"Journal of Sexual Medicine"},{"key":"10.1016\/j.ejpb.2025.114831_b0375","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jsps.2019.09.006","article-title":"Progesterone loaded thermosensitive hydrogel for vaginal application: Formulation and in vitro comparison with commercial product","volume":"27","author":"Vel\u00e1zquez","year":"2019","journal-title":"Saudi Pharmaceutical Journal"},{"key":"10.1016\/j.ejpb.2025.114831_b0380","unstructured":"R. Rupp, S.L. Rosenthal, L.R. Stanberry, VivaGel TM (SPL7013 Gel): A candidate dendrimer-microbicide for the prevention of HIV and HSV infection, 2007."},{"key":"10.1016\/j.ejpb.2025.114831_b0385","doi-asserted-by":"crossref","DOI":"10.3390\/polym13152450","article-title":"Multipurpose prevention technologies: Oral, parenteral, and vaginal dosage forms for prevention of hiv\/stis and unplanned pregnancy","volume":"13","author":"Young","year":"2021","journal-title":"Polymers (basel)"},{"key":"10.1016\/j.ejpb.2025.114831_b0390","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.actbio.2018.10.003","article-title":"Design and development of pH-responsive polyurethane membranes for intravaginal release of nanomedicines","volume":"82","author":"Kim","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2025.114831_b0395","doi-asserted-by":"crossref","unstructured":"M.-D. Veiga-Ochoa, R. Ruiz-Caro, R. Cazorla-Luna, A. Mart\u00edn-Illana, F. Notario-P\u00e9rez, Vaginal Formulations for Prevention of Sexual Transmission of HIV, in: Advances in HIV and AIDS Control, IntechOpen, 2018. Doi: 10.5772\/intechopen.78314.","DOI":"10.5772\/intechopen.78314"},{"key":"10.1016\/j.ejpb.2025.114831_b0400","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2478\/acph-2019-0030","article-title":"Clinical testing of antiretroviral drugs as future prevention against vaginal and rectal transmission of HIV infection \u2013 a review of currently available results","volume":"69","author":"Vyslou\u017eil","year":"2019","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ejpb.2025.114831_b0405","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1021\/acsabm.8b00146","article-title":"Switchable On-demand Release of a Nanocarrier from a Segmented Reservoir Type Intravaginal Ring Filled with a pH-responsive Supramolecular polyurethane Hydrogel","volume":"1","author":"Kim","year":"2018","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.ejpb.2025.114831_b0410","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jcis.2023.05.165","article-title":"Dian Permana, Development of probiotic loaded multilayer microcapsules incorporated into dissolving microneedles for potential improvement treatment of vulvovaginal candidiasis: a proof of concept study","author":"Kristina Enggi","year":"2023","journal-title":"J Colloid Interface Sci 648"},{"key":"10.1016\/j.ejpb.2025.114831_b0415","first-page":"1678","article-title":"Dual delivery systems combining nanocrystals and dissolving microneedles for improved local vaginal delivery of fluconazole, Drug Deliv","volume":"14","author":"Aziz","year":"2024","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejpb.2025.114831_b0420","doi-asserted-by":"crossref","DOI":"10.34133\/2020\/2760594","article-title":"Living Bacterial Microneedles for Fungal Infection Treatment","volume":"2020","author":"Wang","year":"2020","journal-title":"Research"},{"key":"10.1016\/j.ejpb.2025.114831_b0425","doi-asserted-by":"crossref","unstructured":"P. Udayakumar, N. \u0160kalko-Basnet, C.F. Salas Cotaquispe, L.M. Hemmingsen, G. Sotiriou, J. Du, A. Teleki, Microneedles loaded with lipid nanocarriers for local treatment of vulvovaginal candidiasis, (2024). Doi: 10.26434\/chemrxiv-2024-fj3gp.","DOI":"10.26434\/chemrxiv-2024-fj3gp"},{"key":"10.1016\/j.ejpb.2025.114831_b0430","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.2147\/IJN.S211691","article-title":"Azithromycin-liposomes as a novel approach for localized therapy of cervicovaginal bacterial infections","volume":"14","author":"Vani\u0107","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejpb.2025.114831_b0435","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejpb.2016.12.029","article-title":"PEGylated liposomes for topical vaginal therapy improve delivery of interferon alpha","volume":"113","author":"J\u00f8raholmen","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114831_b0440","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejps.2015.09.007","article-title":"Resveratrol-loaded liposomes for topical treatment of the vaginal inflammation and infections","volume":"79","author":"J\u00f8raholmen","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114831_b0445","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejps.2017.11.029","article-title":"Controlled-release biodegradable nanoparticles: from preparation to vaginal applications","volume":"115","author":"Mart\u00ednez-P\u00e9rez","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114831_b0450","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.colsurfb.2018.11.048","article-title":"Miconazole loaded chitosan-based nanoparticles for local treatment of vulvovaginal candidiasis fungal infections","author":"Amaral","year":"2019","journal-title":"Colloids Surf B Biointerfaces 174"},{"key":"10.1016\/j.ejpb.2025.114831_b0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115608","article-title":"Amphotericin B-loaded Eudragit RL100 nanoparticles coated with hyaluronic acid for the treatment of vulvovaginal candidiasis","author":"Melo","year":"2020","journal-title":"Carbohydr Polym 230"},{"key":"10.1016\/j.ejpb.2025.114831_b0460","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3390\/nano11020311","article-title":"Recent advances in Nanosystems and strategies for Vaginal delivery of Antimicrobials","volume":"11","author":"Chindamo","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ejpb.2025.114831_b0465","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1872211313666190215141507","article-title":"Nanocarriers for Vaginal Drug delivery","volume":"13","author":"Iqbal","year":"2019","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"10.1016\/j.ejpb.2025.114831_b0470","doi-asserted-by":"crossref","unstructured":"A. Effinger, C.M. O\u2019Driscoll, M. McAllister, N. Fotaki, In Vitro and In Silico ADME Prediction, in: ADME Processes in Pharmaceutical Sciences, Springer International Publishing, Cham, 2018: pp. 301\u2013330. Doi: 10.1007\/978-3-319-99593-9_13.","DOI":"10.1007\/978-3-319-99593-9_13"},{"key":"10.1016\/j.ejpb.2025.114831_b0475","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202100542","article-title":"Recent advances in the Prediction of Pharmacokinetics Properties in Drug Design Studies: a Review","volume":"17","author":"Pantale\u00e3o","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejpb.2025.114831_b0480","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2019.01.002","article-title":"Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers","volume":"143","author":"Zhao","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2025.114831_b0485","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2174\/1567201819666220413131243","article-title":"Emerging Trends and potential prospects in Vaginal Drug delivery","volume":"20","author":"Mahant","year":"2023","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejpb.2025.114831_b0490","doi-asserted-by":"crossref","unstructured":"M.M. El-Hammadi, J.L. Arias, Nanomedicine for vaginal drug delivery, in: Theory and Applications of Nonparenteral Nanomedicines, Elsevier, 2021: pp. 235\u2013257. Doi: 10.1016\/B978-0-12-820466-5.00011-9.","DOI":"10.1016\/B978-0-12-820466-5.00011-9"},{"key":"10.1016\/j.ejpb.2025.114831_b0495","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11111996","article-title":"Vaginal ph value for clinical diagnosis and treatment of common vaginitis","volume":"11","author":"Lin","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.ejpb.2025.114831_b0500","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17040527","article-title":"A Fungistatic Strategy using a Shear-Thinning pH-responsive CMCS-OHA-Lp\/Lr Hydrogel for Vulvovaginal Candidiasis","volume":"17","author":"Zhao","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114831_b0505","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3390\/ma15010327","article-title":"Recent advances in the Excipients used in Modified Release Vaginal Formulations","volume":"15","author":"Dedeloudi","year":"2022","journal-title":"Materials"},{"key":"10.1016\/j.ejpb.2025.114831_b0510","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejps.2017.11.006","article-title":"A novel double-layer mucoadhesive tablet containing probiotic strain for vaginal administration: Design, development and technological evaluation","volume":"112","author":"S\u00e1nchez","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114831_b0515","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.actbio.2017.10.014","article-title":"Entirely S-protected chitosan: a promising mucoadhesive excipient for metronidazole vaginal tablets","volume":"64","author":"Lupo","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2025.114831_b0520","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.enzmictec.2003.12.013","article-title":"Application of chitin- and chitosan-based materials for enzyme immobilizations: a review","volume":"35","author":"Krajewska","year":"2004","journal-title":"Enzyme Microb. Technol."},{"key":"10.1016\/j.ejpb.2025.114831_b0525","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/pharmaceutics11010020","article-title":"Chitosan-based Mucoadhesive Vaginal Tablets for Controlled Release of the Anti-HIV Drug Tenofovir","volume":"11","author":"Cazorla-Luna","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114831_b0530","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejps.2007.11.004","article-title":"Chitosan citrate as multifunctional polymer for vaginal delivery","volume":"33","author":"Bonferoni","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114831_b0535","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejps.2018.10.013","article-title":"Freeze-dried bioadhesive vaginal bigels for controlled release of Tenofovir","volume":"127","author":"Mart\u00edn-Illana","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114831_b0540","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s11095-012-0715-7","article-title":"Vaginal Film Drug delivery of the Pyrimidinedione IQP-0528 for the Prevention of HIV Infection","volume":"29","author":"Ham","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114831_b0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118958","article-title":"Optimized hydration dynamics in mucoadhesive xanthan-based trilayer vaginal films for the controlled release of tenofovir","volume":"278","author":"Mart\u00edn-Illana","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejpb.2025.114831_b0550","doi-asserted-by":"crossref","first-page":"40","DOI":"10.14227\/DT250318P40","article-title":"Simulated genital tract fluids and their applicability in drug release\/dissolution testing of vaginal dosage forms","volume":"25","author":"Tietz","year":"2018","journal-title":"Dissolut. Technol."},{"key":"10.1016\/j.ejpb.2025.114831_b0555","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-5173(00)00649-9","article-title":"A novel pH- and time-based multi-unit potential colonic drug delivery system","author":"Gupta","year":"2001","journal-title":"I. Development, Int J Pharm 213"},{"key":"10.1016\/j.ejpb.2025.114831_b0560","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.msec.2012.12.040","article-title":"Clotrimazole-loaded Eudragit\u00ae RS100 nanocapsules: Preparation, characterization and in vitro evaluation of antifungal activity against Candida species","volume":"33","author":"Santos","year":"2013","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejpb.2025.114831_b0565","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijpharm.2010.10.032","article-title":"pH-sensitive Eudragit nanoparticles for mucosal drug delivery","volume":"403","author":"Yoo","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114831_b0570","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ejpb.2011.06.007","article-title":"pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission","volume":"79","author":"Zhang","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114831_b0575","first-page":"275","article-title":"Development of a novel synergistic thermosensitive gel for vaginal candidiasis: an in vitro, in vivo evaluation","author":"Mohd","year":"2013","journal-title":"Colloids Surf B Biointerfaces 103"},{"key":"10.1016\/j.ejpb.2025.114831_b0580","article-title":"Enzyme responsive vaginal microbicide gels containing maraviroc and tenofovir microspheres designed for acid phosphatase-triggered release for pre-exposure prophylaxis of HIV-1: a comparative analysis of a bigel and thermosensitive gel","volume":"8","author":"Ekama","year":"2022","journal-title":"Gels"},{"key":"10.1016\/j.ejpb.2025.114831_b0585","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11100511","article-title":"Development of a mucoadhesive in Situ gelling formulation for the delivery of Lactobacillus gasseri into vaginal cavity","volume":"11","author":"Vigani","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114831_b0590","doi-asserted-by":"crossref","first-page":"312","DOI":"10.18433\/J3HP41","article-title":"Ay Senyigit, strategies to Prolong the Intravaginal Residence Time of Drug delivery Systems","volume":"12","author":"Baloglu","year":"2009","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114831_b0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.bea.2025.100163","article-title":"Dual probiotic and antibiotic therapy targeting bacterial vaginosis: an integrated experimental\/computational modeling perspective","volume":"9","author":"Fotouh","year":"2025","journal-title":"Biomed. Eng. Adv."},{"key":"10.1016\/j.ejpb.2025.114831_b0600","first-page":"295","article-title":"Silver secnidazole nano-hybrid emulsion-based probiotics as a novel antifungal formula against multidrug-resistant vaginal pathogens","author":"Mosallam","year":"2024","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.ejpb.2025.114831_b0605","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1155\/S1064744901000394","article-title":"The inhibitory effect of clindamycin on Lactobacillus in vitro","volume":"9","author":"Aroutcheva","year":"2001","journal-title":"Infect. Dis. Obstet. Gynecol."},{"issue":"2017","key":"10.1016\/j.ejpb.2025.114831_b0610","first-page":"938","article-title":"Vaginal bacteria modify HIV tenofovir microbicide efficacy in african women","volume":"356","author":"Klatt","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.ejpb.2025.114831_b0615","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99545","article-title":"Vaginal microbiome modulates topical antiretroviral drug pharmacokinetics","volume":"3","author":"Taneva","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejpb.2025.114831_b0620","article-title":"Development and optimization of a new tioconazole vaginal mucoadhesive film using an experimental design strategy","volume":"205","author":"Calvo","year":"2021","journal-title":"Physicochemical and Biological Characterization, J Pharm Biomed Anal"},{"key":"10.1016\/j.ejpb.2025.114831_b0625","doi-asserted-by":"crossref","DOI":"10.4314\/tjpr.v9i4.58924","article-title":"Bioadhesive Controlled Release Clotrimazole Vaginal Tablets","volume":"9","author":"Bhat","year":"2010","journal-title":"Trop. J. Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114831_b0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032728","article-title":"Commensal Bacteria Modulate Innate Immune responses of Vaginal Epithelial Cell Multilayer Cultures","volume":"7","author":"Rose","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2025.114831_b0635","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.1038\/s41598-020-62184-8","article-title":"Inflammatory and antimicrobial properties differ between vaginal Lactobacillus isolates from South african women with non-optimal versus optimal microbiota","volume":"10","author":"Manhanzva","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2025.114831_b0640","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/infdis\/jiu004","article-title":"Bacteria in the Vaginal Microbiome Alter the Innate Immune Response and Barrier Properties of the Human Vaginal Epithelia in a Species-specific Manner","volume":"209","author":"Doerflinger","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejpb.2025.114831_b0645","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/17512433.2021.1917373","article-title":"The effect of different contraceptive methods on the vaginal microbiome","volume":"14","author":"Bastianelli","year":"2021","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114831_b0650","article-title":"Development of 3D-printed vaginal devices containing metronidazole for alternative bacterial vaginosis treatment","volume":"5","author":"Utomo","year":"2023","journal-title":"Int J Pharm X"},{"key":"10.1016\/j.ejpb.2025.114831_b0655","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.03340","article-title":"Cultivated Human Vaginal Microbiome Communities Impact Zika and Herpes Simplex Virus Replication in ex vivo Vaginal Mucosal Cultures","volume":"9","author":"Amerson-Brown","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejpb.2025.114831_b0660","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/QAI.0000000000000702","article-title":"Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings, JAIDS","volume":"70","author":"Chen","year":"2015","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.ejpb.2025.114831_b0665","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","article-title":"Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women","volume":"375","author":"Nel","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejpb.2025.114831_b0670","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/QAI.0000000000001455","article-title":"Brief Report: Dapivirine Vaginal Ring Use does not Diminish the Effectiveness of Hormonal Contraception","volume":"76","author":"Balkus","year":"2017","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.ejpb.2025.114831_b0675","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.00168","article-title":"Gardnerella vaginalis as a Cause of Bacterial Vaginosis: Appraisal of the evidence from in vivo Models","volume":"10","author":"Morrill","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejpb.2025.114831_b0680","doi-asserted-by":"crossref","DOI":"10.3389\/frph.2021.714829","article-title":"Characterization of the Ovine Vaginal Microbiome and Inflammation patterns as an improved Testing Model of Human Vaginal Irritation","volume":"3","author":"Pyles","year":"2021","journal-title":"Frontiers in Reproductive Health"},{"key":"10.1016\/j.ejpb.2025.114831_b0685","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/QAI.0000000000002244","article-title":"Brief Report: phase IIa Safety Study of a Vaginal Ring Containing Dapivirine in Adolescent Young Women","volume":"83","author":"Bunge","year":"2020","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.ejpb.2025.114831_b0690","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1093\/infdis\/jiw184","article-title":"The Vaginal Microbiome: Current Understanding and Future Directions","volume":"214","author":"Martin","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejpb.2025.114831_b0695","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217229","article-title":"Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir\/ levonorgestrel vaginal rings","volume":"14","author":"Thurman","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2025.114831_b0700","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11904-017-0362-z","article-title":"The Vaginal Microbiome and its potential to Impact Efficacy of HIV Pre-exposure Prophylaxis for Women","volume":"14","author":"Velloza","year":"2017","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.ejpb.2025.114831_b0705","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1208\/s12248-021-00602-z","article-title":"Perspectives on existing and Novel Alternative Intravaginal Probiotic delivery Methods in the Context of Bacterial Vaginosis Infection","volume":"23","author":"Chandrashekhar","year":"2021","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2025.114831_b0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121040","article-title":"Recent advances in electrospun nanofiber vaginal formulations for women\u2019s sexual and reproductive health","volume":"607","author":"Cazorla-Luna","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114831_b0715","first-page":"1","article-title":"Electrospun Nanofibers as Carriers of Microorganisms, Stem Cells, Proteins, and Nucleic Acids in Therapeutic and other applications, Front Bioeng","volume":"8","author":"Stojanov","year":"2020","journal-title":"Biotechnol"},{"key":"10.1016\/j.ejpb.2025.114831_b0720","first-page":"105","article-title":"Enhanced viability of Lactobacillus spp. via encapsulation in hyaluronan\/PVA hybrid electrospun composites for vaginal drug delivery, Futur","volume":"10","author":"Ilomuanya","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114831_b0725","doi-asserted-by":"crossref","DOI":"10.1002\/admt.202201723","article-title":"The history of Electrospinning: past, present, and Future Developments","volume":"8","author":"Keirouz","year":"2023","journal-title":"Adv. Mater. Technol."},{"key":"10.1016\/j.ejpb.2025.114831_b0730","article-title":"Computational modeling of 3D-printed Lactobacillus-antibiotic scaffolds for bacterial vaginosis","author":"Rai","year":"2021","journal-title":"University of Louisville"},{"key":"10.1016\/j.ejpb.2025.114831_b0735","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jconrel.2023.04.023","article-title":"Fabrication and characterization of bioprints with Lactobacillus crispatus for vaginal application","volume":"357","author":"Kyser","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114831_b0740","article-title":"Recent advances on 3D\u2010bioprinted gelatin methacrylate hydrogels for tissue engineering in wound healing: a review of current applications and future prospects","volume":"21","author":"Wang","year":"2024","journal-title":"Int. Wound J."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125002085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125002085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T15:18:34Z","timestamp":1756912714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125002085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":148,"alternative-id":["S0939641125002085"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114831","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancements in drug delivery systems for women\u2019s reproductive health: Vaginal microbiome as a target for innovative drug delivery systems","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114831"}}